DRG has launched New Diabetes Kits:
-
Ultrasensitive Insulin (Human) ELISA
-
Ultrasensitive C-Peptide (Human) ELISA
These two ultrasensitive assays are for testing when a measurement of an extra sensitive and specific quantitative determination of a sample is needed.
|
Assay Specifications |
|
|
|
|
Assay Specifications |
|
| EIA-6055 |
Insulin US (Human) CE |
EIA-6056 |
C-Peptide US (Human) CE |
|||
| Principle: |
Sandwich ELISA |
Principle: |
Sandwich ELISA |
|||
| Sample Type: | Serum or plasma |
Sample Type: |
Serum or plasma |
|||
| Sample Volume: |
50 µL |
Sample Volume: |
50 µL |
|||
| Assay Incubation: |
120 / 20 min RT |
Assay Incubation: |
120 / 20 min RT |
|||
| Assay Range: |
0.05 - 12 mIU/L |
Assay Range: |
0.67 - 700 pg/mL |
|||
| Precision: |
6.3 - 9.9 % |
Precision: |
4.5 - 7.1 % |
|||
| Calibration: |
International Standard 83/500 |
Calibration: |
International Standard 13/146 | |||
| Clinical relevance: |
- Diabetes - Insulin resistance - Cushing's syndrome - Acromegaly - Insulinoma |
Clinical relevance: |
- Differentiation of type 1 & 2 diabetes - Atherosclerosis - Chemotactic effects on inflammation |
|||
| Advantages: |
- Short assay time - Very good sensitivity - Calibrated against Intl. Standard |
Advantages: |
- Very good sensitivity - Calibrated against Intl. Standard |
